Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;57(3):106306.
doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann

Philippe Gautret  1 , Van Thuan Hoang  2 , Philippe Colson  3 , Didier Raoult  3
Affiliations

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann

Philippe Gautret et al. Int J Antimicrob Agents. 2021 Mar.
No abstract available

PubMed Disclaimer

References

    1. Seligmann H. Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment. Int J Antimicrobial Agents (in press). - PMC - PubMed
    1. Gautret P., Lagier J.C., Parola P., Hoang V.T., Meddeb L., Mailhe M. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1) - PMC - PubMed
    1. Gautret P., Hoang V.T., Lagier J.C., Raoult D. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021;57(1) - PMC - PubMed
    1. Gautret P., Hoang V.T., Lagier J.C., Raoult D. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021;57(1) - PMC - PubMed
    1. Gautret P., Hoang V.T., Chaudet H., Lagier J.C., Raoult D. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021;57(1) - PMC - PubMed

MeSH terms